Discover
SNOA
Sonoma Pharmaceuticals, Inc.
1.18
22 x 1.09
1 x 1.31
bid
ask
-
0.02
1.26%
11:32 AM
timesize
| Ytd | -67.58% | |
| 1y | -66.85% |
1.16
day range
1.18
0.85
52 week range
6.92
| Open | 1.17 | Prev Close | 1.20 | Low | 1.16 | High | 1.18 | Mkt Cap | 2.01M |
| Vol | 4.55K | Avg Vol | 238.23K | EPS | -0.94 | P/E | -1.27 | Forward P/E | -1.49 |
| Beta | 1.27 | Short Ratio | 0.22 | Inst. Own | 2.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 1.16 | 200-d Avg | 2.58 | 1yr Est | 19.50 |
| Income Statement | |||
| Total Revenue | 5.56M | ||
| Revenues (USD) | 5.56M | ||
| Cost of Revenue | 3.38M | ||
| Gross Profit | 2.18M | ||
| Operating Expenses | 2.53M | ||
| Research and Development Expense | 545.00K | ||
| Selling, General and Administrative Expense | 1.99M | ||
| Operating Income | -351.00K | ||
| Income Tax Expense | 84.00K | ||
| Net Income | -581.00K | ||
| Net Income Common Stock | -581.00K | ||
| Net Income Common Stock (USD) | -581.00K | ||
| Consolidated Income | -581.00K | ||
| Earnings per Basic Share | -0.33 | ||
| Earnings per Basic Share (USD) | -0.33 | ||
| Earnings per Diluted Share | -0.33 | ||
| Earning Before Interest & Taxes (EBIT) | -497.00K | ||
| Earning Before Interest & Taxes (USD) | -497.00K | ||
| Weighted Average Shares | 1.74M | ||
| Weighted Average Shares Diluted | 1.74M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.40M | ||
| Cash and Equivalents (USD) | 2.40M | ||
| Trade and Non-Trade Receivables | 2.53M | ||
| Current Assets | 12.10M | ||
| Property, Plant & Equipment Net | 912.00K | ||
| Total Assets | 13.96M | ||
| Debt Current | 373.00K | ||
| Total Debt | 842.00K | ||
| Current Liabilities | 4.83M | ||
| Debt Non-Current | 469.00K | ||
| Total Liabilities | 10.87M | ||
| Accumulated Retained Earnings (Deficit) | -200.98M | ||
| Accumulated Other Comprehensive Income | -3.24M | ||
| Shareholders Equity | 3.10M | ||
| Shareholders Equity (USD) | 3.10M | ||
| Assets Non-Current | 1.86M | ||
| Total Debt (USD) | 842.00K | ||
| Deferred Revenue | 284.00K | ||
| Inventory | 3.65M | ||
| Liabilities Non-Current | 6.03M | ||
| Trade and Non-Trade Payables | 1.92M | ||
| Tax Assets | 884.00K | ||
| Tax Liabilities | 5.56M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 33.00K | ||
| Net Cash Flow from Financing | 387.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -162.00K | ||
| Capital Expenditure | -29.00K | ||
| Issuance (Purchase) of Equity Shares | 161.00K | ||
| Issuance (Repayment) of Debt Securities | -51.00K | ||
| Net Cash Flow from Investing | -29.00K | ||
| Net Cash Flow from Operations | -519.00K | ||
| Effect of Exchange Rate Changes on Cash | -1000 | ||
| Share Based Compensation | 135.00K | ||